文献速递生殖医学产科

玻璃化复苏单囊胚移植周期中一步法与序贯法培养液体系对产科和围产结局的影响

Obstetric and perinatal outcomes after embryos cultured in one-step versus sequential culture media systems in vitrified-warmed single blastocyst transfer cycles.
PubMed 文献 · Reprod Biomed Online · 2023-05-04

回顾性队列研究纳入2013至2020年间玻璃化复苏单囊胚移植后单胎分娩的2475名女性,其中1478例胚胎使用Irvine CSC培养液、997例使用Vitrolife G5TM PLUS培养液。两组早产、出生体重、Z评分、大于胎龄儿、小于胎龄儿、低出生体重、巨大儿及新生儿性别分布均无显著差异;G5TM PLUS组妊娠期高血压疾病粗率高于CSC组(4.7% vs 3.0%,P=0.031),校正关键混杂因素后不再显著(校正OR 1.49,95%CI 0.94-2.38,P=0.087)。

要点

  • 玻璃化复苏单囊胚移植中,CSC与G5TM PLUS培养液的新生儿出生结局无显著差异。
  • G5TM PLUS组妊娠期高血压疾病粗发生率4.7%高于CSC组3.0%,校正后差异不再显著。
  • 两组妊娠期糖尿病、未足月胎膜早破、胎盘异常、产后出血及分娩方式均相似。

核心结论

  • 在仅比较Irvine CSC与Vitrolife G5TM PLUS的玻璃化复苏单囊胚移植周期中,胚胎培养液不影响出生结局和产科并发症。

研究设计与样本

  • 回顾性队列研究,纳入2013至2020年间玻璃化复苏单囊胚移植后单胎分娩的女性,胚胎分别使用Irvine Continuous Single Culture(CSC)培养液或Vitrolife G5TM PLUS培养液体系培养。
  • 最终分析共2475名单胎分娩女性,其中1478例胚胎培养于CSC,997例胚胎培养于G5TM PLUS。

主要发现

  • 早产、平均出生体重、按胎龄和性别校正的出生体重(Z评分)、大于胎龄儿率、小于胎龄儿率、低出生体重率、巨大儿率及新生儿性别分布在粗分析和校正分析中两组均无显著差异。
  • G5TM PLUS组妊娠期高血压疾病发生率高于CSC组(4.7% vs 3.0%,P=0.031),校正多个关键混杂因素后差异不再显著(校正OR 1.49,95%CI 0.94至2.38,P=0.087)。
  • 妊娠期糖尿病、未足月胎膜早破、胎盘异常、产后出血及分娩方式两组均相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does type of culture medium used influence obstetric and perinatal outcomes after vitrified-warmed single blastocyst transfers? DESIGN: Retrospective cohort study involving singletons after vitrified-warmed single blastocyst embryo transfers, using embryos cultured in either Irvine Continuous Single Culture medium (CSC) or Vitrolife G5TM PLUS medium culture system between 2013 and 2020. RESULTS: A total of 2475 women who had singleton deliveries were included for final analysis: 1478 had embryos cultured in CSC and 997 had embryos cultured in G5TM PLUS medium. Birth outcomes, including preterm birth, mean birth weight, gestational age- and sex-adjusted birth weight (Z-scores), rates of large-for-gestational-age, small-for-gestational-age, low birth weight and macrosomia, and the distribution of newborn gender did not differ significantly between groups in crude and adjusted analyses. Women whose embryos were cultured in G5TM PLUS frequently suffered from pregnancy-induced hypertensive disorders compared with those who had embryos cultured in CSC (4.7% versus 3.0%; P = 0.031). This difference was no longer significant after adjusting for several key confounders (adjusted odds ratio 1.49, 95% CI 0.94 to 2.38, P = 0.087). Other obstetric complications, including gestational diabetes mellitus, preterm premature rupture of membranes, abnormal placentation, postpartum haemorrhage and the mode of delivery were all similar between the two groups. CONCLUSIONS: The present study adds new information to the current evidence by suggesting that the embryo culture medium does not affect birth outcomes and obstetric complications when comparison is limited to Irvine CSC and Vitrolife G5TM PLUS in vitrified-warmed single blastocyst transfer cycles.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Chen D, Xu Q, Mao X, et al. Obstetric and perinatal outcomes after embryos cultured in one-step versus sequential culture media systems in vitrified-warmed single blastocyst transfer cycles. Reprod Biomed Online. 2023. PMID: 37270369. doi:10.1016/j.rbmo.2023.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。